Cost-effectiveness analysis of a psoriasis care instruction programme with dithranol compared with UVB phototherapy and inpatient dithranol treatment

British Journal of Dermatology

Volumn 147, Issue 3, 2002, Pages 538-544

  Hartman, M ^a   Prins, M ^a   Swinkels, O Q J ^a   Severens, J L ^a   De Boo, Th ^a   Van Der Wilt, G J ^a   Van De Kerkhof, P C M ^a   Van Der Valk, P G M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cost effectiveness analysis; Dithranol; Inpatient dithranol; Psoriasis; Short contact dithranol; UVB phototherapy

Indexed keywords

DITHRANOL;

ADULT; ARTICLE; CALCULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; DRUG CLEARANCE; FEMALE; FOLLOW UP; HEALTH CARE COST; HEALTH PROGRAM; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHOTOTHERAPY; PRIORITY JOURNAL; PSORIASIS; RANDOMIZED CONTROLLED TRIAL; RELAPSE; REMISSION; SHORT COURSE THERAPY; TREATMENT OUTCOME; ULTRAVIOLET B RADIATION;

ADMINISTRATION, TOPICAL; ADULT; AMBULATORY CARE; ANTHRALIN; ANTI-INFLAMMATORY AGENTS; COMBINED MODALITY THERAPY; COST-BENEFIT ANALYSIS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEALTH CARE COSTS; HOSPITAL COSTS; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; PSORIASIS; TREATMENT OUTCOME; ULTRAVIOLET THERAPY;

EID: 0036046144     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2002.04920.x     Document Type: Article

References (18)

1. Current consensus and update on psoriasis therapy: A perspective from the U.S.
2. The management of psoriasis
3. Treatment with UV-B for psoriasis and nonmelanoma skin cancer: A systematic review of the literature
4. Dithranol
5. Treatment of psoriasis: Day care vs. inpatient therapy
6. The benefits, costs and risks of topical tar preparations in the treatment of psoriasis: Considerations of cost effectiveness
7. The annual cost of psoriasis
8. Assessment of disease progress in psoriasis
9. Statistical analysis of cost outcomes in a randomized controlled clinical trial
10. Pulling cost-effectiveness analysis up by its bootstraps: A non-parametric approach to confidence interval estimation
11. Uncertainty in the economic evaluation of health care technologies: The role of sensitivity analysis
12. Psoriasis
13. Costs of psoriasis in the Netherlands
14. Psoriasis treatment and a day-care centre: Clinical aspects and an attempt at a cost-benefit analysis
15. Uncertainty of incremental cost-effectiveness ratios. A comparison of Fieller and Bootstrap confidence intervals